Company Financials
4basebio PLC Financials
Pound sterling
business
4basebio PLC Company Profile
Main Stock Listing
LSE: 4BB
Market Capitalization £152.5 Million as of July 1, 2025
Market Cap History
Valuations Metrics as of May. 5, 2024
| Trailing PE | -2571.43 |
| Forward PE | -18.00 |
| Price to Sales TTM | £390.67 |
| Price to Book MRQ | £3898.92 |
| Enterprise to Revenue | 385.21 |
| Enterprise to EBITDA | -21.46 |
Financial Reports as of Jun. 30, 2023
Financials
| Fiscal Year Ends | 2022-12-31 |
| Most Recent Quarter | 2023-06-30 |
| Profit Margin | 89.18% |
| Operating Margin | -1581.51% |
| Return on Assets TTM | -35.08% |
| Return on Equity TTM | -97.29% |
Income Statement
| Revenue TTM | £354,000 |
| Revenue per Share TTM | £0.03 |
| Quarterly Revenue Growth | 56.60% |
| Gross Profit TTM | £239,000 |
| EBITDA | £-6,355,000 |
| Net Income to Common TTM | £-6,275,000 |
| Diluted EPS TTM | £-0.51 |
| Quarterly Earnings Growth YoY | % |
Balance Sheet
| Total Cash MRQ | £3,558,000 |
| Total Cash per Share MRQ | £0.29 |
| Total Debt MRQ | £ |
| Total Debt to Equity MRQ | 201.47 |
| Current Ratio MRQ | 3.42 |
| Book Value per Share MRQ | £0.28 |
Cash Flow
| Operating Cash Flow TTM | £-5,224,000 |
| Levered Free Cash Flow TTM | £-5,198,649 |
4BB Stock Info as of May. 5, 2024
Stock Statistics
| Shares Outstanding | 12,805,200 |
| Float Shares | 4,211,905 |
| Avg 10 Volume | 1,142 |
| Avg 30 Volume | None |
| Shares Short | None |
| Short Ratio | |
| Short % of Shares | % |
| % Held by Insiders | 62.19% |
| % Held by Institutions | 9.04% |
Stock Price Summary
| Beta | 1.13 |
| Fifty Two Week Low | £492.00 |
| Fifty Two Week High | £1120.00 |
| Fifty Two Week Change | 43.06% |
| Day 50 MA | £962.30 |
| Day 200 MA | £699.53 |
Dividends and Splits
| Forward Annual Dividend Rate | £ |
| Forward Annual Dividend Yield | % |
| Trailing Annual Dividend Rate | £0.00 |
| Trailing Annual Dividend Yield | 0.00% |
| Payout Ratio | 0.00% |
| Dividend Date | |
| Ex Dividend Date | |
| Last Split Factor | |
| Last Split Date |